Clinical Trials Logo

Survivorship clinical trials

View clinical trials related to Survivorship.

Filter by:

NCT ID: NCT06442397 Not yet recruiting - Survivorship Clinical Trials

Anti-Inflammatory Lifestyle Intervention for Emerging Adult Cancer Survivors

Start date: June 15, 2024
Phase: N/A
Study type: Interventional

To test the feasibility and acceptability of AILI and associated research procedures among emerging adult cancer survivors (EACS) age 18-29.

NCT ID: NCT06439316 Completed - Cancer Clinical Trials

Physical Function and Mental Health in Cancer Survivors

Start date: January 1, 2007
Phase:
Study type: Observational

The goal of this observational study is to evaluate the joint prognostic effects of physical function and mental health on survival of cancer survivors.

NCT ID: NCT06411704 Recruiting - Frailty Clinical Trials

Remote Exercise Video Adaptations to Maximize Physical Activity in Childhood Cancer

Start date: May 2024
Phase:
Study type: Observational

The goal of this observational study is to leverage childhood cancer survivor input to adapt video content of a digital video disc-(DVD) delivered evidence-based PA intervention, originally designed for community-dwelling older adults. Primary Objective: - To leverage childhood cancer survivor input to adapt video content for an evidence-based remote exercise intervention.

NCT ID: NCT06353178 Recruiting - Cancer Clinical Trials

Building Empowerment and Coping Outcomes for caNcer Patients, Survivors and Their Caregivers

BEACON
Start date: April 8, 2024
Phase: N/A
Study type: Interventional

Cancer has a psychological, emotional and social impact beyond a patient's physical health. This study examines three new online peer mental-wellness support program for cancer patients, survivors or their caregivers. Each program teaches evidence-based skills, in the context of that groups lived experience, to manage the emotional impact of cancer. This study examines the impact of that program.

NCT ID: NCT06320223 Recruiting - Prostate Cancer Clinical Trials

PROMISE PET Registry on PSMA-PET and Outcome in Prostate Cancer

PROMISE-PET
Start date: March 5, 2024
Phase:
Study type: Observational [Patient Registry]

Background: PROMISE criteria have been defined for standardized reporting of Prostate-Specific Membrane Antigen (PSMA) PET whole-body stage of prostate cancer. PSMA PET disease extent by PROMISE has been associated with oncologic outcome. Need: Improved prognostication across various stages of prostate cancer is needed for management guidance and study design. Aim: 1. To assess the prognostic value of PSMA PET 2. To compare the prognostic value of PSMA PET with clinical prognostic scores in patients with prostate cancer at various disease stages Inclusion: - Adult patients with - biopsy/histo proven prostate cancer who - underwent PSMA PET (any type) - for staging or re-staging at any stage and who - have at least 3-year overall survival follow-up data available will be included consecutively. Exclusion: - Patients with neuroendocrine prostate cancer - Patients with metastasized or disseminated malignancy other than prostate cancer

NCT ID: NCT06306170 Recruiting - Gynecologic Cancer Clinical Trials

Advanced Radiotherapy (ART) in Gynecological Cancer Patients (GYN-ART)

GYN-ART
Start date: February 15, 2024
Phase:
Study type: Observational

This is an observational mono-institutional study. Patients with gynecologic tumors treated with advanced radiotherapy- Image Guided Radiotherapy (IGRT), Intensity Modulated Radiotherapy (IMRT), Stereotactic Body Radiotherapy (SBRT)- will be included and toxicity and outcomes analyzed.

NCT ID: NCT06292039 Not yet recruiting - Survivorship Clinical Trials

Human-centered Injury Thrivorship Pathway for Survivors of Physical Trauma

Start date: July 2025
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to pilot and evaluate a human-centered injury thrivorship pathway in injury survivors. The main question it aims to answer is: • Is the pathway appropriate, acceptable, and feasible to meet the medical and social needs of injury survivors? Injury survivors will be purposively sampled to enroll in the pathway and asked to participate in in-depth interviews and their use of pathway resources will be tracked.

NCT ID: NCT06284395 Recruiting - Survivorship Clinical Trials

Two Schemes Response in Multiple Myeloma

Start date: November 20, 2023
Phase:
Study type: Observational

Retrospective study based on medical records of patients with multiple myeloma, eligible for stem cell transplantation, who received, first-line, the VTD or TD combination.

NCT ID: NCT06248918 Enrolling by invitation - Health Behavior Clinical Trials

Nurse-led Physical Activity Program Among Breast Cancer Survivors

WATSOCPAP
Start date: March 1, 2024
Phase: N/A
Study type: Interventional

A nurse-led physical activity program including an individualized exercise program using wearable technology and health coaching based on Social Cognitive Theory will be implemented for women surviving cancer. The impact of the nurse-led physical activity program on physical activity level, health-related quality of life and cognitive factors (self regulation, outcome expectation, self efficacy, perceived social support, perceived environment) will be evaluated in the study.

NCT ID: NCT06184256 Not yet recruiting - Cancer Clinical Trials

BfedBwell Optimization Pilot

Start date: July 2024
Phase: N/A
Study type: Interventional

Using the Multiphase Optimization Strategy (MOST) framework, an engineering-based approach to efficiently and systematically develop, optimize, and evaluate behavioral interventions, this study will test three components: (1) 1:1 counseling with a registered dietitian, (2) behavioral skills development, and (3) group support for delivery alongside a core nutrition curriculum within a clinical exercise oncology program.